Correlation between Ratio of Serum Doxycycline Concentration to MIC and Rapid Decline of Antibody Levels during Treatment of Q Fever Endocarditis
- 1 July 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (7) , 2673-2676
Abstract
Endocarditis is the major clinical manifestation of chronic Q fever. Although doxycycline along with hydroxychloroquine remains the mainstay of medical therapy for Q fever endocarditis, there are wide variations in the rapidity of the patient's decline of antibody levels during such therapy. We undertook a retrospective examination of whether there was any correlation between the ratio of serum concentration to MIC of doxycycline and response to treatment in patients with Q fever endocarditis. Included herein are 16 patients from whom Coxiella burnetii was isolated from cardiac valve materials. Serology and measurement of doxycycline and hydroxychloroquine serum levels were performed and recorded after 1 year of treatment. The MIC of doxycycline for C. burnetii isolates was determined using the shell vial assay in a real-time quantitative PCR assay. At the completion of a yearlong therapy with doxycycline-hydroxychloroquine, all those that showed a low decline of antibody levels ( n = 6) (i.e., C. burnetii antigen) had a ratio of serum doxycycline concentration to MIC between 0.5 and 1. In contrast, those having a ratio of ≥1 showed a rapid decline of phase I antibody levels ( n = 9; P < 0.05). The only patient who died had a serum doxycycline-to-MIC ratio of C. burnetii cultured from this patient was resistant to doxycycline (MIC = 8 μg/ml). The ratio of serum doxycycline concentration to MIC should be monitored during the course of therapy in patients with Q fever endocarditis.Keywords
This publication has 23 references indexed in Scilit:
- Tetracycline Resistance inChlamydia suisMediated by Genomic Islands Inserted into the Chlamydialinv-Like GeneAntimicrobial Agents and Chemotherapy, 2004
- Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCRInternational Journal of Antimicrobial Agents, 2004
- Correlation between Serum Doxycycline Concentrations and Serologic Evolution in Patients withCoxiella burnetiiEndocarditisThe Journal of Infectious Diseases, 2003
- Antimicrobial Use and Resistance in AnimalsClinical Infectious Diseases, 2002
- Uses of Antimicrobials in Plant AgricultureClinical Infectious Diseases, 2002
- Changing Clinical Presentation of Q Fever EndocarditisClinical Infectious Diseases, 2002
- Extension of the Lancefield Classification for Group A Streptococci by Addition of 22 New M Protein Gene Sequence Types from Clinical Isolates: emm103 to emm124Clinical Infectious Diseases, 2002
- In Vitro Susceptibility of Coxiella burnetii to Linezolid in Comparison with Its Susceptibilities to Quinolones, Doxycycline, and ClarithromycinAntimicrobial Agents and Chemotherapy, 2001
- Bacteriostatic and Bactericidal Activities of Moxifloxacin against Coxiella burnetiiAntimicrobial Agents and Chemotherapy, 2001
- Phagolysosomal Alkalinization and the Bactericidal Effect of Antibiotics: TheCoxiella burnetii ParadigmThe Journal of Infectious Diseases, 1992